Dentists' Attitudes Towards Pharmacological Management of Acute Pain in Children and Adolescents - a Follow-up Survey
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05911542 |
Recruitment Status :
Recruiting
First Posted : June 22, 2023
Last Update Posted : April 30, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of this study is to investigate Swedish dentists' attitudes about pain management when treating children and adolescents by assessing 1) dentists' recommendations for the use of pre- and postoperative analgesics, (2) use of local anaesthesia during treatment of primary and permanent teeth, and (3) if the use of these strategies differs between General Dental Practitioners (GDP) and Specialist Paediatric Dentists (SPD).
All Swedish SPDs (including post-graduate dentists in paediatric dentistry), circa 150 in total, and approximately 1,000 GDPs in County Skåne, Sweden will be invited to answer a questionnaire.
Condition or disease | Intervention/treatment |
---|---|
Pain Management | Behavioral: Survey |
This survey study is follow-up to a survey carried out in 2014, addressed to Swedish General Dental Practitioners (GDPs) and Specialist Paediatric Dentists (SPDs). The aim of this study is to investigate Swedish dentists' attitudes about pain management when treating children and adolescents by assessing 1) dentists' recommendations for the use of pre- and postoperative analgesics, 2) use of local anaesthesia during treatment of primary and permanent teeth, and 3) if the use of these strategies differs between GDPs and SPDs.
All SPDs (including post-graduate dentists in paediatric dentistry) in Sweden, circa 150 in total, and approximately 1,000 GDPs, will be invited to answer the questionnaire. To be included GDPs need to have registered addresses in county Skåne, Sweden, and be accredited to provide dental care to children and adolescents by Region Skåne, the regional public health and dental care provider. A questionnaire along with written information about the study and two consent forms will be mailed to presumptive study participants. Those willing to participate in the study are asked to return (postage prepaid) one signed consent form and the completed questionnaire. The questionnaire is adapted from one previously used in Sweden. It contains demographic questions, and questions regarding work situation. These questions are followed by four clinical scenarios, and questions relating to use of pain management practices. Responses are given on a 5-point Likert scale. The final questions are open ended and concern the use of pre- and postoperative analgesics.
Study Type : | Observational |
Estimated Enrollment : | 1150 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | Dentists' Attitudes Towards Pharmacological Management of Acute Pain in Children and Adolescents - a Follow-up Survey |
Actual Study Start Date : | April 1, 2023 |
Estimated Primary Completion Date : | December 1, 2026 |
Estimated Study Completion Date : | December 31, 2026 |
Group/Cohort | Intervention/treatment |
---|---|
General Dental Practitioners
Participants are asked to complete a survey about pain management strategies.
|
Behavioral: Survey
Participants complete survey about pain management practices |
Specialist Paediatric Dentists
Participants are asked to complete a survey about pain management strategies.
|
Behavioral: Survey
Participants complete survey about pain management practices |
- Attitudes towards management of acute pain [ Time Frame: 4 months ]Dentists' attitudes towards pharmacological management of acute pain in children and adolescents measured on a 5 point Likert scale, ranging from 'always' to 'never'.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 64 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Probability Sample |
Inclusion Criteria:
General Dental Practitioners with a civil registration address in County Skåne, Sweden.
Specialist Paediatric Dentists in Sweden.
Exclusion Criteria:
Not accredited to provide dental care to children and adolescents (applies to General Dental Practitioners).
≥ 65 years of age
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05911542
Contact: Rikard Roxner, MScDSc | +46(0)406658480 | rikard.roxner@mau.se | |
Contact: Henrik Berlin, PhD | +46(0)406658488 | henrik.berlin@mau.se |
Sweden | |
Malmö University | Recruiting |
Malmö, Skåne, Sweden, 205 06 | |
Contact: Rikard Roxner, MScDSc +46 40 665 84 80 rikard.roxnmer@mau.se |
Principal Investigator: | Gunilla Klingberg, Professor | Malmö University |
Responsible Party: | Malmö University |
ClinicalTrials.gov Identifier: | NCT05911542 |
Other Study ID Numbers: |
FO 2021/536 |
First Posted: | June 22, 2023 Key Record Dates |
Last Update Posted: | April 30, 2024 |
Last Verified: | April 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Acute Pain Pain Neurologic Manifestations |